Prevalence of the Coprescription of Clinically Important Interacting Drug Combinations Involving Oral Anticancer Agents in Singapore: A Retrospective Database Study

Clinical Therapeutics - Tập 34 - Trang 1696-1704 - 2012
Yu Ko1, Sze-Ling Daphne Tan1, Alexandre Chan1,2, Yuet-Peng Wong3, Wei-Peng Yong4, Raymond Chee-Hui Ng5, Siew-Woon Lim3, Agus Salim6
1Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore
2Department of Pharmacy, National Cancer Center Singapore, Singapore
3Department of Pharmacy, National University Hospital, Singapore
4Department of Hematology Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore
5Department of Medical Oncology, National Cancer Center, Singapore, Singapore
6Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Tài liệu tham khảo

Blower, 2005, Drug-drug interactions in oncology: why are they important and can they be minimized?, Crit Rev Oncol Hematol, 55, 117, 10.1016/j.critrevonc.2005.03.007 Mamun, 2004, Polypharmacy and inappropriate medication use in Singapore nursing homes, Ann Acad Med Singapore, 33, 49 Aisner, 2007, Overview of the changing paradigm in cancer treatment: oral chemotherapy, Am J Health Syst Pharm, 64, 54, 10.2146/ajhp070035 Weingart, 2008, NCCN Task Force Report: oral chemotherapy, J Natl Compr Canc Netw, 6, S1, 10.6004/jnccn.2008.2003 Borner, 2001, Answering patients' needs: oral alternatives to intravenous therapy, Oncologist, 6, 12, 10.1634/theoncologist.6-suppl_4-12 Riechelmann, 2005, Potential for drug interactions in hospitalized cancer patients, Cancer Chemother Pharmacol, 56, 286, 10.1007/s00280-004-0998-4 Riechelmann, 2007, Potential drug interactions and duplicate prescriptions among cancer patients, J Natl Cancer Inst, 99, 592, 10.1093/jnci/djk130 Riechelmann, 2008, Potential drug interactions in cancer patients receiving supportive care exclusively, J Pain Symptom Manage, 35, 535, 10.1016/j.jpainsymman.2007.06.009 Riechelmann, 2007, Drug combinations with the potential to interact among cancer patients, Support Care Cancer, 15, 1113, 10.1007/s00520-007-0274-3 Voll, 2010, Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs, Pharm World Sci, 32, 575, 10.1007/s11096-010-9410-0 Cheung, 2010, Drug-drug interactions between oral antiepileptics and oral anticancer drugs: implications to clinicians, Eur Neurol, 64, 88, 10.1159/000315031 Micromedex Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically. Tatro, 2010 Johnell, 2007, The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register, Drug Saf, 30, 911, 10.2165/00002018-200730100-00009 Mahmood, 2007, Potential drug-drug interactions within Veterans Affairs medical centers, Am J Health Syst Pharm, 64, 1500, 10.2146/ajhp060548 Roughead, 2010, Prevalence of potentially hazardous drug interactions amongst Australian veterans, Br J Clin Pharmacol, 70, 252, 10.1111/j.1365-2125.2010.03694.x Brouwers, 1994, Pharmacokinetic-pharmacodynamic drug-interactions with nonsteroidal antiinflammatory drugs, Clin Pharmacokinet, 27, 462, 10.2165/00003088-199427060-00005 Frenia, 1992, Methotrexate and nonsteroidal antiinflammatory drug-interactions, Ann Pharmacother, 26, 234, 10.1177/106002809202600219 Vonbach, 2007, Risk factors for gastrointestinal bleeding: a hospital-based case-control study, Swiss Med Wkly, 137, 705 Baer, 1987, Transient fall in serum salicylate levels following intraarticular injection of steroid in patients with rheumatoid arthritis, Arthritis Rheum, 30, 345, 10.1002/art.1780300315 Bardare, 1978, Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis, Arch Dis Child, 53, 381, 10.1136/adc.53.5.381 Edelman, 1986, The effect of intra-articular steroids on plasma salicylate concentrations, Br J Clin Pharmacol, 21, 301, 10.1111/j.1365-2125.1986.tb05194.x Koren, 1987, Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis, Ther Drug Monit, 9, 177, 10.1097/00007691-198706000-00009 Cruciol-Souza, 2006, Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital, J Pharm Pharm Sci, 9, 427 Doubova, 2007, Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City, BMC Health Serv Res, 7, 147, 10.1186/1472-6963-7-147 Janchawee, 2005, Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand, J Clin Pharm Ther, 30, 13, 10.1111/j.1365-2710.2004.00598.x Aparasu, 2007, Clinically important potential drug-drug interactions in outpatient settings, Res Social Adm Pharm, 3, 426, 10.1016/j.sapharm.2006.12.002 Gagne, 2008, Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy, J Clin Pharm Ther, 33, 141, 10.1111/j.1365-2710.2007.00891.x Nobili, 2009, Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database, J Clin Phar Ther, 34, 377, 10.1111/j.1365-2710.2009.01021.x Xie, 2005, Are they being used safely?, Hum Psychopharmacol Clin Exp, 20, 459, 10.1002/hup.711 Tobi, 2007, Studying co-medication patterns: the impact of definitions, Pharmacoepidemiol Drug Saf, 16, 405, 10.1002/pds.1304